# Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia

> **NCT00358852** · — · COMPLETED · sponsor: **Janssen-Cilag, S.A.** · enrollment: 2339 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT00358852
- **Lead sponsor:** Janssen-Cilag, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 2339 (ACTUAL)
- **Last updated:** 2014-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358852, "Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00358852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*